These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 228015)

  • 21. Immunobiology of primary intracranial tumors. Part 4: levamisole as an immune stimulant in patients and in the ASV glioma model.
    Mahaley MS; Steinbok P; Aronin P; Dudka L; Zinn D
    J Neurosurg; 1981 Feb; 54(2):220-7. PubMed ID: 6256510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery: final report of an RTOG study.
    Nelson DF; Diener-West M; Weinstein AS; Schoenfeld D; Nelson JS; Sause WT; Chang CH; Goodman R; Carabell S
    Int J Radiat Oncol Biol Phys; 1986 Oct; 12(10):1793-800. PubMed ID: 3531110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bax expressed from a herpes viral vector enhances the efficacy of N,N'-bis(2-hydroxyethyl)-N-nitrosourea treatment in a rat glioma model.
    Lee A; DeJong G; Guo J; Bu X; Jia WW
    Cancer Gene Ther; 2000 Aug; 7(8):1113-9. PubMed ID: 10975671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Injection of chemotherapeutic microspheres and glioma. IV: Eradicating tumors in rats.
    Emerich DF; Winn SR; Bartus RT
    Cell Transplant; 2002; 11(1):47-54. PubMed ID: 12095219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved treatment of a brain-tumor model. Part 2: Sequential therapy with BCNU and 5-fluorouracil.
    Gerosa MA; Dougherty DV; Wilson CB; Rosenblum ML
    J Neurosurg; 1983 Mar; 58(3):368-73. PubMed ID: 6827321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival response of malignant gliomas to radiotherapy with or without BCNU or methyl-CCNU chemotherapy at the University of Kentucky Medical Center.
    Chin HW; Young AB; Maruyama Y
    Cancer Treat Rep; 1981; 65(1-2):45-51. PubMed ID: 7013978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the lipid-soluble diaminopyrimidines, metoprine and etoprine, in the avian sarcoma virus rat glioma model.
    Serano RD; Sigel CW; Nichol CA; Bigner DD
    Cancer Treat Rep; 1982 Jan; 66(1):99-106. PubMed ID: 6272992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunobiology of primary intracranial tumors.
    Mahaley MS; Gentry RE; Bigner DD
    J Neurosurg; 1977 Jul; 47(1):35-43. PubMed ID: 194022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemotherapy of malignant gliomas: studies of the BTCG.
    Shapiro WR
    Rev Neurol (Paris); 1992; 148(6-7):428-34. PubMed ID: 1448662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized comparisons of radiotherapy and carmustine versus procarbazine versus dacarbazine for the treatment of malignant gliomas following surgery: a Southwest Oncology Group Study.
    Eyre HJ; Eltringham JR; Gehan EA; Vogel FS; Al-Sarraf M; Talley RW; Costanzi JJ; Athens JW; Oishi N; Fletcher WS
    Cancer Treat Rep; 1986 Sep; 70(9):1085-90. PubMed ID: 3017551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase II trial of thalidomide and carmustine for patients with recurrent high-grade gliomas.
    Fine HA; Wen PY; Maher EA; Viscosi E; Batchelor T; Lakhani N; Figg WD; Purow BW; Borkowf CB
    J Clin Oncol; 2003 Jun; 21(12):2299-304. PubMed ID: 12805330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose escalation of carmustine in surgically implanted polymers in patients with recurrent malignant glioma: a New Approaches to Brain Tumor Therapy CNS Consortium trial.
    Olivi A; Grossman SA; Tatter S; Barker F; Judy K; Olsen J; Bruce J; Hilt D; Fisher J; Piantadosi S;
    J Clin Oncol; 2003 May; 21(9):1845-9. PubMed ID: 12721262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma.
    Green SB; Byar DP; Walker MD; Pistenmaa DA; Alexander E; Batzdorf U; Brooks WH; Hunt WE; Mealey J; Odom GL; Paoletti P; Ransohoff J; Robertson JT; Selker RG; Shapiro WR; Smith KR; Wilson CB; Strike TA
    Cancer Treat Rep; 1983 Feb; 67(2):121-32. PubMed ID: 6337710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sister chromatid exchange induction in patients with anaplastic gliomas undergoing treatment with radiation plus diaziquone or 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Kligerman AD; Erexson GL; Wilmer JL; Schold SC
    Cancer Res; 1987 Jan; 47(2):631-5. PubMed ID: 3791247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of perfluorochemicals on BCNU chemotherapy: preliminary study in a rat brain tumor model.
    Kokunai T; Kuwamura K
    Surg Neurol; 1982 Oct; 18(4):258-61. PubMed ID: 7179085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of autochthonous rat brain tumors with chemotherapy and radiotherapy].
    Nakamura O; Matsutani M; Nomura K; Shitara N; Takakura K; Ishizaki R
    Gan To Kagaku Ryoho; 1987 Apr; 14(4):1069-74. PubMed ID: 3032111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interstitial docetaxel (taxotere), carmustine and combined interstitial therapy: a novel treatment for experimental malignant glioma.
    Sampath P; Rhines LD; DiMeco F; Tyler BM; Park MC; Brem H
    J Neurooncol; 2006 Oct; 80(1):9-17. PubMed ID: 16636748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined modality approach to treatment of malignant gliomas--re-evaluation of RTOG 7401/ECOG 1374 with long-term follow-up: a joint study of the Radiation Therapy Oncology Group and the Eastern Cooperative Oncology Group.
    Nelson DF; Diener-West M; Horton J; Chang CH; Schoenfeld D; Nelson JS
    NCI Monogr; 1988; (6):279-84. PubMed ID: 3281031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BCNU (NSC-409962) and procarbazine (NSC-77213) treatment for malignant brain tumors.
    Levin VA; Crafts DC; Wilson CB; Schultz MJ; Boldrey EB; Enot KJ; Pischer TL; Seager M; Elashoff RM
    Cancer Treat Rep; 1976 Mar; 60(3):243-9. PubMed ID: 177210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjuvant therapy with dibromodulcitol and BCNU increases survival of adults with malignant gliomas. EORTC Brain Tumor Group.
    Hildebrand J; Sahmoud T; Mignolet F; Brucher JM; Afra D
    Neurology; 1994 Aug; 44(8):1479-83. PubMed ID: 8058153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.